CD47 and neoplasm: The interaction between CD47 and signal regulatory protein alpha (SIRPα) directly hinders the phagocytosis of tumor cells by macrophages, leading to a subsequent impairment in the presentation of tumor antigens to T lymphocytes [7–9].